Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) (DREAMM 5)

2019 ◽  
Author(s):  
Keyword(s):  
Multiple Myeloma ◽  
Cancer Treatments ◽  
Refractory Multiple Myeloma ◽  
Anti Cancer

Unstable Plasma Thalidomide Concentration in Patients with Refractory Multiple Myeloma

2004 ◽  
Vol 10 (3) ◽  
pp. 132-136 ◽  
Author(s):  
TOMOKO KODAMA ◽  
RYUYA HORIUCHI ◽  
NORIFUMI TSUKAMOTO ◽  
YOSHIHISA NOJIMA ◽  
HIROKAZU MURAKAMI
Keyword(s):  
Multiple Myeloma ◽  
Refractory Multiple Myeloma ◽  
Unstable Plasma
Sign in / Sign up

Export Citation Format

Share Document